AngioDynamics (ANGO) Tops Q3 EPS by 14c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.37 -0.16%
Revenue Growth %: +0.0%
Financial Fact:
Net sales: 88.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +0.0%
Financial Fact:
Net sales: 88.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.14 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $72 million versus the consensus estimate of $70.57 million.
GUIDANCE:
AngioDynamics sees FY2025 EPS of ($0.31)-($0.34), versus the consensus of ($0.35). AngioDynamics sees FY2025 revenue of $285-288 million, versus the consensus of $284.9 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Lockheed Martin wins $8.4B missile contract modification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
